 CAMBRIDGE, Mass. and NEW YORK, June 06, 2022 GLOBE NEWSWIRE -- Black Diamond Therapeutics, Inc. Nasdaq: BDTX, a precision oncology medicine company pioneering the discovery and development of MasterKey therapies, today announced that its President and Chief Executive Officer, David M. Epstein, Ph.D., will present an update on the Companys progress at the Jefferies Global Healthcare Conference on Wednesday, June 8, 2022, at 3:00pm ET in New York, NY. 